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Abstract 
Stress-related processes have been implicated in the associations between lower socioeconomic status 
(SES), central adiposity, and cardiovascular disease risk. This study analysed the impact of SES and 
central adiposity on cardiovascular, inflammatory and neuroendocrine stress responses, and 
associations with cytomegalovirus (CMV) infection in a sample of 537 men and women aged 53-76 
years (mean 62.89 years). SES was defined by grade of employment (higher, intermediate, and lower 
categories), and central adiposity was indexed by waist-hip ratio (WHR). Cardiovascular, inflammatory 
and cortisol responses were monitored during administration of a standardized mental stress testing 
protocol and salivary cortisol was measured repeatedly over the day. Lower SES was associated with 
raised systolic and diastolic blood pressure (BP), plasma interleukin (IL-6), fibrinogen, C-reactive 
protein, and salivary cortisol, and a large WHR accentuated SES differences in fibrinogen, C-reactive 
protein, and likelihood of CMV seropositivity, independently of general adiposity indexed by body 
mass index. During mental stress testing, return to resting levels (recovery) following behavioural 
challenge in systolic and diastolic BP and heart rate was impaired among lower SES participants, 
particularly those with large WHR. Lower SES participants had greater cortisol concentrations across 
the day, but this pattern did not vary with WHR.  These findings extend the evidence relating lower 
SES to stress-related biological risk factors for cardiovascular disease, and indicate that central 
adiposity may augment these effects. 
Keywords: Stress reactivity; Interleukin 6; Obesity; Cytomegalovirus; Cortisol; Blood pressure  
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1.   Introduction 
There are marked socioeconomic disparities in cardiovascular disease (CVD), with greater incidence of 
coronary heart disease (CHD), hypertension and stroke in lower socioeconomic status (SES) groups 
defined by occupation, education, income or self-defined social status (Kerr et al., 2011; Leng et al., 
2015; Manrique-Garcia et al., 2011; Tang et al., 2016). Lifestyle factors such as smoking and sedentary 
behaviour make an important contribution to SES differences (Stringhini et al., 2011), but direct 
influences on biological processes implicated in CVD are also relevant (Kivimaki and Steptoe, 2018). 
Psychological stress elicits disturbances in autonomic regulation, neuroendocrine factors, inflammatory 
markers and endothelial function (Boylan et al., 2018; Marsland et al., 2017; Wirtz and von Kanel, 
2017). Studies of acute mental stress have shown that lower SES is associated with delayed recovery 
(return towards baseline after stress) in systolic and diastolic blood pressure (BP) and in haemostatic 
variables, together with elevated concentration of markers of inflammation such as interleukin 6 (IL-6) 
(Boylan et al., 2018; Brydon et al., 2004). These responses are markers of chronic allostatic load 
(McEwen and Gianaros, 2010), and predict future cardiovascular morbidity (Panaite et al., 2015; 
Steptoe et al., 2016). 
 Central or visceral adiposity is a growing health problem, and is a pivotal risk factor for 
cardiometabolic disease (Balkau et al., 2007; Despres, 2012). Fat deposits in the abdominal visceral 
region are highly active in terms of autonomic, immune and neuroendocrine regulation, with 
inflammation, sympathetic nervous system activation, and disturbances of hypothalamic-pituitary-
adrenocortical (HPA) function being implicated in central adiposity (Bjorntorp, 2001; Mancia et al., 
2007; Speaker and Fleshner, 2012). Psychological stress may contribute to the development of central 
adiposity through alterations in stress biology (Dallman et al., 2005; Tomiyama, 2018). A positive 
association between central adiposity, inflammatory cytokine responses, and delayed BP recovery 
following acute mental stress has been described (Brydon et al., 2008; McInnis et al., 2014; Steptoe and 
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Wardle, 2005), although an inverse association with heart rate and cortisol responses to stress has also 
been noted (Jones et al., 2012; Phillips et al., 2012).  
Since central adiposity is more common among lower than higher SES groups, it is possible that 
the two share common pathways to cardiovascular risk through disturbed stress biology. However, the 
combined effect of lower SES and central adiposity has not previously been examined. We therefore 
investigated the impact of SES and central adiposity on inflammatory, hemodynamic and 
neuroendocrine responses to psychological stress in a sample of healthy middle-aged and older men 
and women drawn from the Whitehall II epidemiologic cohort. We hypothesized that lower SES and 
greater central adiposity would be associated with delayed cardiovascular (BP and heart rate) recovery 
following acute stress, with greater inflammatory responses to stress, greater cortisol output over the 
day, and with higher baseline levels. We further conjectured that these two factors might be synergistic, 
with the greatest responses emerging among lower SES individuals with greater central adiposity. 
being present Because the focus of this study was on central adiposity, body mass index (BMI) was 
included as a covariate in the analyses to take account of overall adiposity. 
We also evaluated associations between SES and central adiposity and cytomegalovirus (CMV) 
serostatus. Herpesviruses such as CMV are frequently acquired early in life, and are more common 
among lower SES individuals as defined by education, poverty or parental occupational status (Dowd 
et al., 2012; Janicki-Deverts et al., 2014; Simanek et al., 2009). Positive CMV serostatus has been 
shown to predict future cardiovascular disease (Hui et al., 2016; Ji et al., 2012), and is implicated in 
inflammatory diseases and in the dysregulation of the hypothalamic-pituitary-adrenocortical (HPA) 
axis as well. We have previously found that CMV is associated with a flatter cortisol rhythm over the 
day, and with accelerated telomere shortening over three years (Dowd et al., 2017; Steptoe et al., 2009). 
CMV also affects metabolic processes, though associations with adiposity are poorly understood 
(Fleck-Derderian et al., 2017). Associations between CMV seropositivity, SES and central adiposity 
were therefore assessed in this study. 
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2.  Methods 
2.1  Participants 
We recruited a sample of 543 healthy white European men (n=294) and women (n=249) aged 53-76 
years (M=62.89 ± 5.65) from the Whitehall II epidemiological cohort of British civil servants (Marmot 
et al., 1991). To be included in the study the participants were required to have no history of CHD, 
hypertension, inflammatory conditions or allergies. These criteria were used because the overarching 
aim of the study was to investigate psychosocial and biological risk factors for CHD (Hackett et al., 
2012; Steptoe et al., 2010).  Since one of the primary purposes of the study was to compare SES 
groups, we used a stratified sampling method to recruit potential participants from higher, intermediate, 
and lower grade of employment categories in the Whitehall II cohort. Because of the differences in 
cardiovascular disease across the socioeconomic gradient, there were fewer lower than higher or 
intermediate grade disease-free individuals eligible for the study, so the lower grade group was smaller. 
Participants were instructed not to take any anti-inflammatory or anti-histamine medication in the 
seven days prior to the testing day and to refrain from drinking alcohol and excessive exercise from the 
previous evening. The participants were also required to avoid caffeinated beverages and smoking at 
least 2 hours prior to the testing session. Individuals presenting with colds or infections on the testing 
day were rescheduled. Civil service employment grade was used to divide participants into low, 
intermediate and high SES groups. Waist-hip ratio (WHR) was used to divide participants into low and 
high central adiposity groups with sex-specific median cut points (men 0.943, women 0.801). Six 
participants were excluded from the analysis because of incomplete data.  All participants gave full 
informed consent and the study was approved by the University College London Hospitals Committee 
on the Ethics of Human Research. 
2.2   Procedures 
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Questionnaires were completed before the mental stress testing sessions that were conducted 
individually in a light and temperature controlled laboratory in either the morning or the afternoon 
between 2006 and 2008. At the start of the session, anthropometric measurements were taken. Height 
was measured to the nearest 0.1cm using a stadiometer and weight was measured in kilos (kg) using 
Tanita Scales. Body Mass Index (BMI) was subsequently calculated using this information 
(kg/metres
2
). Waist circumference was assessed using a metal tape halfway between the bottom rib and 
iliac crest, and hip circumference was measured at the level of the great trochanters. The measurements 
were conducted twice to ensure accuracy, and WHR was calculated as waist circumference/hip 
circumference.   
Following these measurements, the participant was seated and a venous cannula was inserted 
into the lower arm for the collection of blood samples. Systolic BP, diastolic BP and heart rate were 
assessed continuously using a Finometer (Finapres Medical Systems, Amsterdam).  There followed a 
30 minute resting period, the last 5 minutes of which was used to measure baseline systolic and 
diastolic BP and heart rate. At this time the first blood sample was drawn into EDTA and citrated tubes, 
and a saliva sample was taken using Salivettes (Sarstedt, Leicester, UK).  
Two 5-minute behavioural tasks that have been used to induce stress in a number of previous 
studies were then administered in a counterbalanced order (Steptoe et al., 2002b). These tasks have 
been shown to elicit consistent cardiovascular and inflammatory responses on repeat testing (Hamer et 
al., 2006). The first was a computerized version of the Stroop colour-word-interference task. 
Participants had to press a computer key to choose one out of four words that matched the colour of the 
target word presented at the centre of the screen. Target and distractor words were printed in 
incongruous colours (e.g. the word blue printed in red, etc.). The second task was mirror tracing, 
involving the tracing of a star with a metal stylus which could only be seen in mirror image. The device 
emitted a loud beep with every error. Participants were told that people usually manage to finish five 
circuits of the star during the allocated time.  
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A second blood sample and a saliva sample were taken immediately after the tasks, while 
systolic and diastolic BP and heart rate were measured continuously throughout the tasks and recovery 
period. Further blood samples were obtained 45 minutes and 75 minutes after task completion, with 
saliva samples at 20, 45 and 75 minutes during the recovery period.  
Following the mental stress testing session, participants were asked to take 5 saliva samples 
over the next day, following methods previously used in this laboratory (Kunz-Ebrecht et al., 2004). 
Samples were requested on waking, 30 min later, at 10:00h, 16:00h and 20:00h, and were sent back to 
the research office and stored at -20
o
 C.    
2.3.  Blood and salivary measures 
Blood samples were centrifuged immediately at 2500 rpm for 10 minutes at room temperature and the 
separated plasma was aliquoted into 0.5 ml portions stored at -80 °C until further analysis. Three 
inflammatory markers were analysed. Plasma IL-6 was assayed using a Quantikine high sensitivity 
two-site enzyme-linked immunosorbent assay (ELISA) from R&D Systems (Oxford, UK). The 
sensitivity of the assay ranged from 0.016 to 0.110 pg/ml and the intra and inter assay CVs were 7.3% 
and 7.7% respectively. Fibrinogen was measured from citrated blood with an automated Clauss assay 
in a MDA-180 coagulometer (Oragon Teknika, Cambridge, UK) using the manufacturer's reagents and 
the International Fibrinogen Standard, with inter- and intra-individual CVs of 8% (Gaffney and Wong, 
1992). High sensitivity C-reactive protein was assayed in duplicate with a high sensitivity enzyme 
immunoassay kit (BioCheck, CA, USA). Glycated haemoglobin (HbA1c) was measured using a Tosoh 
G7 high performance liquid chromatography analyser (San Francisco, CA) calibrated to Diabetes 
Control and Complications Trial standards. CMV IgG antibody titres were measured from thawed 
serum samples using a solid-phase enzyme immunoassay system as described previously (Dowd et al., 
2013). A sample was categorized as seropositive if the optical density ratio was 1.0 or greater as read 
by a spectrophotometer. All CMV assays were carried out by the Stanley Neurovirology Laboratory of 
the Johns Hopkins University School of Medicine. Saliva samples were stored at -20 °C until analysis 
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at the University of Dresden. Cortisol levels were assessed from saliva using a time resolved 
immunoassay with fluorescence detection, and the intra- and inter-assay coefficients of variation (CVs) 
were less than 8%.  
2.4   Statistical analyses 
Sociodemographic factors were compared across SES and WHR groups using analysis of variance for 
continuous and Chi
2 
tests for categorical variables. Cardiovascular data were averaged over 4 periods: 
the last 5 minutes of the baseline period (baseline), the two behavioural task trials, and 40-45 min and 
70-75 min following tasks (recovery phase). Heart rate variability was modelled as root mean square of 
successive differences (RMSSD) over the same time periods, and was log transformed before analysis 
because of negative skew. The total cortisol output over the stress session was computed using the area 
under the curve (AUC) method (Pruessner et al., 2003), and a similar method was used to quantify 
cortisol output over the day. Cortisol over the day was negatively skewed so log transformed before 
analysis, but raw values are shown in the Results section. There were 41 women with current or recent 
hormone replacement treatment, but including this factor into account did not modify the results, so it 
was not included in the final models. 
Baseline values of biomarkers were analysed by analysis of covariance with SES (grade of 
employment) and central adiposity (WHR) group as between-person factors, covarying for age, sex, 
and smoking status, since these potentially influence results. Analyses of salivary cortisol also included 
time of day of laboratory session (morning/afternoon) as a covariate. In order to identify effects related 
specifically to central adiposity, BMI was added as a further covariate to all analyses. Linear contrasts 
tested gradients across SES groups. The number of participants included in each analysis differed 
because of missing data, so the sample sizes are indicated in the Results.  
Stress responses were analysed using repeated measures analysis of variance with SES and 
WHR as between-person factors and trial as the within-person factor. There were 4 trials in the 
cardiovascular and IL-6 analyses: baseline, during task for cardiovascular variables and immediately 
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after tasks for IL-6, and 45 and 75 min after tasks. Fibrinogen was sampled at 3 time points since levels 
return to baseline promptly after stress: baseline, immediately after tasks, and at 45 min (Steptoe et al., 
2003b). Salivary cortisol was analysed across 5 trials (baseline, immediately after tasks, and 20, 45 and 
75 min after tasks), and also by analysing the AUC for the session. The Greenhouse–Geisser correction 
of degrees of freedom was applied where appropriate. Stress reactivity was further analysed with 
difference scores between baseline and stress tasks, while post-stress recovery in cardiovascular 
variables was assessed as differences between task and recovery trials, with higher values indicating 
greater recovery. 
C-reactive protein and HbA1c were measured once, and were analysed in the same fashion as 
the baseline values of biomarkers. We analysed CMV serostatus using logistic regression, and present 
the odds of CMV positivity (with 95% confidence intervals, CI) adjusted for age, sex, smoking status 
and BMI, with the higher SES / small WHR group as the reference category. 
We also carried out two sensitivity analyses. First, we investigated the impact of WHR 
modelled as a continuously distributed as opposed to a categorical variable. Because of sex differences 
in WHR, normalised scores were used in these analyses. Second, we reanalysed all data with only SES 
and WHR in the models, without covarying for age, sex, smoking status, and BMI.   
 
3.  Results 
There were 207 higher, 209 intermediate and 121 lower SES participants as defined by occupational 
grade (Table 1). There was a significant difference in age across SES groups (F(2,531) = 4.23, p  = 
0.015, since the lower SES participants were slightly older on average. Lower SES participants were 
more likely to be unmarried (p = 0.007), while educational attainment was positively associated with 
SES, with a substantially greater number of higher than lower SES volunteers being educated to 
University level (p <0.001). There was no difference in the proportion of participants in the small and 
large WHR categories across SES groups, and no difference in gender distribution. As might be 
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expected, BMI, average waist circumference and average hip circumference were all greater in the 
large than small WHR groups (p <0.001). Additionally, there was a non-linear SES difference in waist 
circumference (p = 0.007), with slightly larger waists on average in intermediate than higher or lower 
SES respondents. There was a moderate positive correlation between WHR and BMI (r = 0.41), but 
tests for multicollinearity (variance inflation factors and tolerance) were all within acceptable ranges. 
Measures of task appraisal showed no differences related to SES or WHR in the extent to which tasks 
were perceived as difficult, involving, or controllable (results not shown). 
3.1  Resting differences in biological activity  
Baseline levels of cardiovascular, inflammatory and other biological measures are summarized in Table 
2, adjusted for age, sex, smoking status and BMI. There were significant SES gradients in systolic and 
diastolic BP (F(2,512) = 10.28 and 7.47, p <0.001), with lower BP in higher status participants. There 
were no SES differences in heart rate or heart rate variability at baseline. Systolic BP was not related to 
WHR, but both diastolic BP and heart rate were higher in the large WHR category after adjusting for 
covariates (F(1,512) = 5.83, p = 0.016 and F (1,469) = 4.40, p =0.037). Baseline plasma IL-6 (F(2,509) 
= 3.03), fibrinogen (F(2,506) = 4.83) and C-reactive protein (F(2,510) = 2.29) all showed significant 
gradients across SES groups (all p = 0.033 or greater), with higher levels of inflammation in lower SES 
groups after adjustment for covariates. There was an SES gradient in baseline salivary cortisol as well 
(F(2,512) = 3.67, p = 0.009), with a higher concentration in lower SES participants. There were no 
significant differences in HbA1c levels. The interaction between SES and WHR was significant for 
plasma fibrinogen, (F(2,506) = 9.46, p <0.001), and C-reactive protein, (F(2,510)= 4.20, p = 0.016). In 
both cases, the highest values were observed in the lower SES / large WHR group. 
3.2  Cardiovascular responses to acute stress 
Repeated measures analysis of variance of systolic BP identified a main effect of SES (F(2,508) = 8.17, 
p <0.001), together with an SES by trial interaction (F(6,1524) = 3.58, p = 0.005), and a 3-way SES by 
WHR by trial cubic effect (F(6,1524) = 3.24, p = 0.040). In the case of diastolic BP, there were main 
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effects of WHR (F(2,507) = 5.73, p = 0.017) and SES (F(2,507) = 7.21, p <0.001), plus significant SES 
by trial (F(6,1521) = 4.50, p <0.001), and SES by WHR by trial cubic effects (F(2,507) = 3.36, p = 
0.036). These results are summarised in Figure 1, where it is apparent that BP increased markedly in 
response to mental stress, returning towards baseline during the recovery period. There was no 
difference in systolic BP reactions to tasks in relation to SES or WHR, but differences emerged during 
the recovery period. After adjustment for age, sex, smoking status and BMI, there was a significant 
SES gradient in the extent of recovery at 45 minutes (F(2,508) = 5.12, p <0.001) and 75 minutes 
following stress (F(2,508) = 12.70, p <0.001). SES effects remained significant after additional control 
for baseline and levels during tasks (F(2,505) = 3.57 and 3.93, p = 0.008 and 0.011 respectively), so 
were not secondary to any differences in baseline or stress reactivity. Additionally, SES and WHR 
interacted in recovery at 45 min (F(2,508) = 4.01, p = 0.019). These results are summarized in Table 3, 
and show that the amount of impaired recovery in the lower SES group was accentuated in the large 
WHR category. A similar pattern emerged for diastolic BP, with SES differences at 45 and 75 min 
(F(2,507) = 6.01 and 7.07, p = 0.003), with a SES and WHR interaction at 45 min showing that central 
adiposity moderated these SES differences (F(2,507) = 4.03, p = 0.018). As in the case of systolic BP, 
SES differences in recovery remained significant following additional adjustment for baseline and task 
levels at 45 min (F(2,504) = 4.57, p = 0.004) and 75 min (F(2,504) = 6.94, p = 0.002). 
 The analysis of heart rate revealed an SES by trial interaction (F(6,1380) = 4.02, p <0.001) and 
a main effect of WHR (F(1, 460) = 4.34, p = 0.034), but no 3-way interaction. In contrast with the BP 
results, there was a significant difference in heart rate reactions across SES groups (F(2,469) = 4.36, p 
= 0.004), with larger increases in the higher SES compared with lower SES participants (see Figure 2). 
However, SES differences in recovery were the same as for BP at 45 min and 75 min (F(2,463) = 4.86 
and 4.59, p =0.004), with more effective recovery among higher SES participants (Table 3). These 
recovery effects remained significant with additional control for baseline levels. Heart rate variability 
also changed in response to the stress protocol (F(3,1314) = 231.5, p < 0.001), falling from baseline 
  
 SES and central adiposity 11 
 
during tasks, and recovering above baseline after tasks. This pattern did not vary with SES, but there 
was a significant WHR by trial interaction (F(3,1302) = 2.81, p = 0.048). Responses to tasks were 
comparable, but the large WHR group showed better post-stress recovery than the small WHR group at 
45 minutes (p = 0.037).  
3.3  Inflammatory and neuroendocrine responses to acute stress 
Plasma IL-6 increased following stress, showing a delayed response with raised levels 45 and 75 min 
after tasks (F(3,1491) = 125.5, p <0.001). There was also a significant SES effect (F(2,493) = 2.30, p = 
0.033), with higher IL-6 concentrations in lower SES participants after adjustment for age, sex, 
smoking status and BMI (Figure 2). The acute inflammatory responses to stress did not differ across 
SES groups, but the highest absolute levels were recorded in lower SES participants following stress. 
Additionally, the WHR group by trial interaction was significant (F(1,493) = 4.74, p = 0.030). The 
large WHR group showed smaller increases in IL-6 concentration over the session after adjustment for 
covariates, but there was no interaction between SES and WHR. The pattern of plasma fibrinogen 
responses differed from that for IL-6, in that increases with tasks were immediate and transient 
(F(2,992) = 4.99, p = 0.007). There was a significant main effect for SES, together with an SES by 
WHR interaction (F(2,496) = 8.29, p  <0.001).  As can be seen in Figure 3, this was primarily 
attributable to the substantially higher concentrations of fibrinogen in the lower SES / large WHR 
group.   
The salivary cortisol AUC showed a main significant effect of SES (F(2,512) = 2.10, p = 0.041, 
mirroring the socioeconomic gradient at baseline described in Table 2. Additionally, analysis of 
individual samples identified an SES by trial interaction illustrated in Figure 3 (F(2,512) = 4.13, p  = 
0.017). The elevated cortisol in the lower SES group is apparent throughout the session, but there is no 
clear relationship with stress responsivity or recovery. 
3.4  CMV serostatus, SES and central adiposity 
  
 SES and central adiposity 12 
 
A substantial proportion of respondents were positive for CMV, indicating that past infection was 
relatively common. Table 4 summarises the results in relation to SES and WHR. Logistic regression 
revealed that the odds of CMV seropositivity were increased more than twofold in the lower SES / 
large WHR group compared with the higher SES / small WHR group after adjustment for covariates (p 
= 0.009). The prevalence of positive CMV serostatus was 44.8% in the higher SES / small WHR group 
compared with 66.0% in the lower SES /large WHR group. 
3.5  Cortisol across the day 
There was a typical salivary cortisol profile across the day, with high values on waking and an increase 
in cortisol 30 minutes later, followed by progressive decline into the evening. Significant differences by 
SES were apparent (F (2,458) = 4.93, p = 0.006), with greater cortisol output among lower SES 
individuals (Figure 4). There was, however, no interaction between SES and time of day, and no SES 
difference in the rise in cortisol between waking and 30 minutes later, or in the slope of cortisol decline 
across the day. Cortisol output over the day was not related to WHR, and there were no significant 
interactions between SES and WHR. Analyses of men and women separately showed no differences in 
these patterns of change over the day (results not shown). 
3.7  Sensitivity analyses 
The first sensitivity analysis investigated whether associations would be different if WHR modelled as 
a continuous variable rather than categorising individuals as having larger or smaller WHR. The 
results, summarised in Appendix A, Table 1, indicate very few differences from the categorical 
analyses. Three interactions between SES and WHR were no longer significant with continuous WHR, 
but there were no differences from the main analysis in baseline or resting effects for systolic or 
diastolic BP, heart rate, HRV, IL-6 , salivary cortisol or CMV serostatus, and no differences from the 
main analysis in reactivity or recovery effects for any outcome apart from diastolic BP. The pattern of 
results for salivary cortisol over the day was unchanged. 
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  The second sensitivity analysis assessed the associations of SES and WHR with biology in the 
absence of statistical adjustment for age, sex, smoking status and BMI. The results are summarised in 
Appendix A, Table 2. Significant associations between WHR and resting HRV and plasma IL-6 
emerged that were not present in the main analysis. In relation to systolic BP, the interaction between 
WHR and trial was significant (this was conditional on SES in the main analysis), and there was a main 
effect of WHR on plasma IL-6, with higher IL-6 in the larger than smaller WHR group throughout the 
session. By contrast, the previously observed WHR by trial interaction was no longer significant. These 
effects primarily emerged because of the absence of BMI as a covariate. Otherwise, there were no 
differences from the main analyses in baseline levels, stress reactivity and recovery, or in cortisol 
output over the day.   
 
4.   Discussion 
This study investigated the separate and combined associations between lower SES and central 
adiposity and a range of stress-related biological processes. We hypothesised that lower SES and 
greater central adiposity (waist-hip ratio) would be associated with impaired post-stress recovery in 
cardiovascular parameters, with heightened inflammatory and neuroendocrine responses to stress, and 
with greater cortisol output over the day. We also conjectured that the combination of lower SES and 
greater central adiposity would be particularly toxic. The results confirmed and extended previous 
studies of SES and cardiovascular, inflammatory and neuroendocrine factors, and identified important 
interactions between lower SES and central adiposity in relation to inflammatory markers, CMV 
infection, and post-stress recovery of cardiovascular function. 
 Associations between SES and acute cardiovascular stress responsivity have been investigated 
in a number of studies. A meta-analysis in 2018 showed no consistent relationship between SES and 
BP or heart rate reactivity, but differences emerged in post-stress recovery, albeit in a sample of only 6 
studies (Boylan et al., 2018). The present results are consistent with these conclusions and with a 
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previous study from our laboratory (Steptoe et al., 2002a), in showing impaired systolic and diastolic 
BP and heart rates recovery following stress in lower SES participants. Heart rate variability did not 
follow this pattern, but was only measured using RMSSD, and frequency-based parameters may have 
been more sensitive. The study population was purposively recruited using a stratified sampling 
procedure to ensure adequate representation of people from different SES groups who were  in good 
cardiometabolic health, assuaging some of the heterogeneity in sampling present in some other studies. 
Interestingly, we observed higher heart rate reactivity to tasks in the higher SES group. A similar 
pattern has been reported previously, and may relate to the performance of cognitive tasks as opposed 
to other types of behavioural challenge (de Rooij, 2013). We selected the tasks in this study after pilot 
work on a number of alternatives, choosing those that were appraised similarly by people across the 
SES spectrum (Steptoe and Marmot, 2002), and there were no differences in task appraisal in the 
present study. 
 Although central adiposity did not affect cardiovascular reactivity or recovery directly, we 
observed interactions between SES and WHR in the post-stress recovery profile of systolic and 
diastolic BP. Blood pressure recovery was markedly impaired in the lower SES /large WHR group. For 
example, the decrease in systolic BP from task levels at 45 minutes averaged 26.6 mmHg in the higher 
SES/small WHR group, 22.15 mmHg in the lower SES/small WHR group, but only 16.22 mmHg in the 
lower SES/large WHR group (Table 3). Impaired post-stress recovery has previously been shown to 
predict clinical hypertension and cardiovascular disease risk (Panaite et al., 2015). Our results suggest 
that this pathway may link greater central adiposity with cardiovascular risk among lower SES adults. 
 Resting values of all three inflammatory markers in this study (C- reactive protein, IL-6 and 
fibrinogen) were inversely associated with SES in a graded fashion (Table 2). This relationship has 
been recorded in larger epidemiological studies as well (Nazmi and Victora, 2007; Steptoe, 2012), and 
suggests that lower SES is characterised by low grade systemic inflammation that may contribute to 
increased risk for several physical and mental health outcomes, particularly at older ages (Franceschi et 
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al., 2018).  The lower SES participants with greater central adiposity had particularly raised levels of 
resting C-reactive protein and plasma fibrinogen compared with other groups, together with sustained 
elevations in fibrinogen throughout the mental stress protocol. Inflammatory processes play a key role 
in linking cardiovascular disease with fat distribution (Ferrucci and Fabbri, 2018). Central or 
abdominal fat stores are a potent source of adipokines while also contributing to high circulating levels 
of very-low-density lipoprotein, reduced high-density lipoprotein concentrations, and excess fatty acid 
flux (Piche et al., 2018). Central adiposity predicts cardiovascular risk independently of total body fat 
or BMI (Abraham et al., 2015; Liu et al., 2010). Plasma IL-6 did not conform to this pattern. The SES 
gradients in IL-6 and fibrinogen present at baseline were sustained throughout the study, but the 
increases in IL-6 concentration following stress occurred in parallel across the three SES groups. So 
although the highest levels were apparent in the lower SES group at 75 minutes post-stress, there was 
no differential reactivity. In a previous study, we observed that IL-6 concentration continued to 
increase among lower SES participants between 75 and 120 minutes following stress, whereas it 
stabilised in the higher SES group (Brydon et al., 2004). It is possible therefore that differences might 
have emerged if blood sampling had continued. Fibrinogen responses were more transient, but again 
occurred in parallel across SES groups, replicating results in an earlier smaller study (Steptoe et al., 
2003a). There was a flatter rise in IL-6 among people with greater WHR, but no interaction with SES. 
 The cortisol responses to this protocol were small, although individual differences still 
predicted variations in cardiovascular risk and telomere attrition longitudinally (Hamer et al., 2012; 
Steptoe et al., 2017). Salivary cortisol was elevated throughout the mental stress testing session in 
lower compared with intermediate and higher SES groups, and lower SES individuals also showed 
greater cortisol output over the day (Figures 2 and 4). There were SES differences in the changes in 
cortisol across the stress session, but it is difficult to interpret these as differences in rate of post-stress 
recovery (Le-Scherban et al., 2018). Studies relating SES with diurnal cortisol profiles have generated 
conflicting results, although several have documented flatter slopes of cortisol recline over the day 
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(Desantis et al., 2015; Hajat et al., 2010). Others have focused on the cortisol awakening response 
(Kunz-Ebrecht et al., 2004). We did not find any differences in the cortisol awakening response or in 
slope of decline over the day, but instead a difference in overall output that was independent of age, 
sex, smoking, and BMI. 
The absence of differences in cortisol responses between WHR groups was unexpected, since 
several previous studies have shown associations (Bjorntorp, 2001; Incollingo Rodriguez et al., 2015). 
It is notable that the majority of studies in this field have assessed associations of cortisol with central 
adiposity without adjusting for BMI as was done in these analyses (Champaneri et al., 2013; Incollingo 
Rodriguez et al., 2015). As can be seen in appendix A, table 2, analyses that did not take general 
adiposity into account revealed more extensive differences related to WHR than did the adjusted 
analyses. But failure to adjust for BMI makes it more difficult to identify specific associations with 
central adiposity. Another explanation for the lack of striking associations with central obesity may 
relate to the study sample. Although the differences in central adiposity between the small and large 
WHR groups were marked, the body weights of this healthy cohort of older men and women were 
generally relatively moderate. It is possible that stress-related biological and psychosocial processes 
implicated in central adiposity will only be manifest among more overweight or obese individuals.  
The interaction between lower SES and greater central adiposity in the proportion of 
respondents with CMV infection has not been documented before (Table 4). A socioeconomic gradient 
in CMV infection has also been noted in population studies (Dowd et al., 2009), and positive serostatus 
predicts all-cause mortality, CHD and hypertension risk (Du et al., 2018; Hui et al., 2016; Simanek et 
al., 2011). Molecular biological studies suggest that the infection is concentrated in endothelial cells 
leading to endothelial injury, subsequently affecting smooth muscle cell proliferation and promoting 
atherogenesis (Du et al., 2018). The present study cannot determine whether lower SES individuals 
with greater abdominal adiposity are at higher risk of infection, or whether CMV infection among 
lower SES groups drives the development of central adiposity. Nonetheless, the interaction suggests 
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that infectious pathways to cardiovascular disease risk may be particularly important among less 
affluent people with central adiposity. 
 This study was carried out with a well characterised population that was selectively sampled to 
encompass a broad range of SES. Existing cardiovascular disease was excluded, so that associations are 
not secondary to differences in health status. The size of the sample was large by comparison with 
many investigations of stress-related inflammatory responses. However, the selection process resulted 
in a sample of individuals with relatively normal body weights, and only 14% had a BMI ≥30. The 
impact of central adiposity may be greater among people who have more general obesity. The study 
was carried out with men and women of white European origin, and results may not generalise to other 
groups. SES was defined by occupational status, and other criteria such as educational attainment or 
income might generate different results. The cross-sectional design makes it impossible to draw causal 
conclusions about the directionality of effects. It is likely that there is a bidirectional relationship 
between central adiposity and stress biology, with greater abdominal fat contributing to the expression 
of adipokines and other markers, while stress stimulates more rapid accumulation of fat stores. 
Findings may also be limited by having only one session of mental stress testing and sampling cortisol 
over a single day. Nonetheless, the findings extend the evidence relating lower SES to stress-related 
biological risk factors for cardiovascular disease, while indicating that central adiposity may augment 
SES differences in inflammation and impaired recovery in cardiovascular function following acute 
mental stress. 
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Table 1  Characteristics of the study sample 
 
  
Socioeconomic status 
 
 Higher (N=207) 
 
Intermediate (N=209) Lower (N=121) 
Waist-hip ratio grouping 
 
Small Large Small Large Small Large 
N 
 
107 100 109 100 52 69 
Age (years) 
 
62.70 (5.78) 61.81 (5.26) 62.57 (5.49) 62.94 (5.56) 63.31 (5.71) 64.94 (6.11) 
Sex (% men) 
 
55 (51.4%) 59 (59.0%) 65 (59.6%) 58 (47.2%) 23 (44.2%) 28 (40.6%) 
Marital status: unmarried (%) 
 
38 (35.5%) 29 (29.3%) 35 (32.1%) 32 (32.0) 22 (42.3%) 35 (50.7%) 
Education to University degree level (%) 61 (57.5%) 68 (68.7%) 30 (28.0%) 18 (18.8%) 4 (8.5%) 5 (8.2%) 
 
Current smokers (%) 
 
4 (3.7%) 6 (6.0%) 2 (1.8%) 10 (10.0%) 5 (9.6%) 3 (4.3%) 
BMI (kg/m
2
) 
 
23.97 (2.84) 27.55 (4.36) 24.72 (3.66) 27.32 (3.65) 23.94 (3.41) 27.51 (3.46) 
Waist circumference (cm) 
 
78.26 (9.35) 95.29 (11.03) 81.46 (10.93) 94.70 (10.68) 77.15 (9.41) 91.50 (9.93) 
Hip circumference (cm) 95.6 (6.24) 101.2 (9.41) 97.7 (7.29) 100.2 (7.86) 95.1 (7.57) 100.6 (8.25) 
 
Values are presented as Means (SD) and N (%) 
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Table 2   Baseline levels of biological measures 
 
  
Socioeconomic status 
 
 Higher (207) 
 
Intermediate (209) Lower (121) 
Waist-hip ratio grouping Small Large Small Large Small Large 
Systolic BP (mmHg) N =522 122.28 (13.95) 124.76 (14.29) 124.44 (14.82) 127.36 (14.41) 132.22 (15.22) 129.96 (14.57) 
Diastolic BP (mmHg) N=520 
 
71.53 (8.51) 74.17 (8.31) 73.41 (10.76) 75.54 (9.82) 76.13 (9.11) 78.08 (10.31) 
Heart rate (bpm) N=479 
 
65.85 (9.20) 67.13 (9.15) 65.81 (9.28) 67.19 (8.88) 65.08 (7.21) 68.28 (9.61) 
Heart rate variability (rms, ln) N=446 
 
3.05 (0.38) 3.09 (0.52) 3.08 (0.45) 3.04 (0.49) 3.07 (0.49) 3.02 (0.55) 
Plasma IL-6 (pg/ml) N=519 
 
1.19 (0.74) 1.28 (0.74) 1.43 (1.02) 1.30 (0.71) 1.32 (0.57) 1.58 (0.93) 
Plasma fibrinogen (g/L) N=516 
 
3.06 (0.52) 3.09 (0.53) 3.20 (0.64) 3.02 (0.61) 3.08 (0.53) 3.48 (0.71) 
Plasma C-reactive protein (mg/L) N =520 
 
1.30 (1.24) 1.70 (2.21) 1.81 (2.34) 1.51 (1.76) 1.47 (1.18) 2.58 (3.69) 
Salivary cortisol (ln, nmol/ml) N = 523 1.84 (0.46) 
 
1.90 (0.46) 1.85 (0.50) 1.92 (0.44) 1.99 (0.47) 2.03 (0.42) 
HbA1c (mmol/mol) N=530 
 
36.1 (3.40) 35.5 (5.04) 36.4 (3.56) 35.9 (4.83) 37.2  (10.30) 36.7 (4.15) 
Values are presented as means (SD) and are adjusted for age, sex, smoking status and BMI. Salivary cortisol additionally adjusted for time of day of stress testing. 
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Table 3   Cardiovascular recovery following stress 
 
  
Socioeconomic status 
 
 Higher (207) 
 
Intermediate (209) Lower (121) 
Waist-hip ratio grouping Small Large Small Large Small Large 
Systolic BP (mmHg)       
  Recovery at 45 min 26.60 (16.72) 22.46 (15.47) 19.45 (14.76) 22.38 (15.88) 22.15 (15.57) 16.22 (15.25) 
  Recovery at 75 min 
 
24.51 (16.36) 21.94 (16.98) 18.98 (14.85) 19.15 (16.79) 18.12 (13.86) 14.09 (13.26) 
Diastolic BP (mmHg) 
 
      
  Recovery at 45 min 
 
11.38 (7.14) 10.04 (7.12) 7.23 (7.55) 9.84 (8.78) 8.63 (6.39) 7.53 (7.03) 
 
  Recovery at 75 min 
 
9.86 (6.85) 9.75 (8.45) 5.66 (7.29) 8.49 (8.18) 7.61 (6.76) 6.86 (7.00) 
Heart rate (bpm) 
 
      
  Recovery at 45 min 
 
11.69 (7.59) 
 
11.94 (7.59) 10.17 (7.19) 10.78 (5.43) 9.58 (5.17) 8.87 (7.48) 
  Recovery at 75 min 
 
11.87 (7.65) 11.48 (7.92) 9.88 (7.17) 10.39 (5.50) 9.20 (6.17) 9.18 (7.19) 
Values are presented as means (SD) and are adjusted for age, sex, smoking status and BMI.  
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Table 4  CMV serostatus, SES and central adiposity 
 
 
Group Percent (95% CI) Adjusted odds ratio 
(95% CI) 
 
p 
 
Higher SES / small WHR 
 
 
44.8% (34.8-54.7) 
 
 
Reference (1) 
 
 
Higher SES / large WHR 
 
47.2% (36.9-57.4) 1.10 (0.61-2.00) 
 
0.75 
Intermediate SES / small WHR 
 
48.2% (38.5-57.8) 1.15 (0.66-2.00) 0.62 
Intermediate SES / large WHR 
 
44.5%  (34.5-54.5) 0.98 (0.54-1.78) 0.96 
Lower SES / small WHR 
 
48.1% (34.2-62.0) 1.14 (0.57-2.29) 0.71 
Lower SES / large WHR 
 
66.0% (53.8-78.3) 2.47 (1.35-4.89) 0.009 
 
Adjusted for age, sex, smoking status and BMI. N = 511. 
SES = socioeconomic status; WHR = waist-hip ratio 
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Figure legends 
 
Figure 1 Mean levels of systolic and diastolic BP in relation to SES and WHR at baseline, during 
tasks, and 40-45 min and 70-75 min after task completion. Lower SES – black; 
Intermediate SES – blue; Higher SES – red; solid lines – large WHR; dashed lines – 
small WHR. Values are adjusted for age, sex, smoking status and BMI. Error bars are 
standard error of the mean (sem). 
Figure 2 Mean levels of heart rate and plasma IL-6 during or immediately after tasks, and 40-45 
min and 70-75 min after task completion. Heart rate results are for SES only, while IL-6 
findings are plotted in relation to SES and WHR. For other details, see legend to Figure 
1. 
Figure 3 Mean levels of plasma fibrinogen and cortisol at baseline, immediately after tasks, and 
at 20 min (cortisol), 45 min and 75 min after task completion. Fibrinogen results are for 
SES and WHR, while cortisol is plotted in relation to SES only. For other details, see 
legend to Figure 1. 
Figure 4  Mean salivary cortisol concentration across the day in relation to SES.  For other details, 
see legend to Figure 1. 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Highlights 
 
 Lower SES is associated with greater inflammation and impaired blood pressure recovery 
 
 SES differences in inflammation are accentuated by central adiposity 
 
 Low SES people with central adiposity have higher rates of cytomegalovirus infection 
 
 Cortisol output over the day is inversely related to SES 
 
 These processes potential link SES and adiposity with cardiovascular disease risk 
 
 
